Toward that goal, a Bio‐Plex MAGPIX Multiplex System was employed to determine the profile of 27 plasma cytokines/chemokines in NSCLC patients who received treatment with PD‐1/PD‐L1 inhibitors alone or in combination with chemotherapy. The gene discussed is CD274; the disease is non-small cell lung carcinoma.